SCHEMBL4929317

SCHEMBL4929317

Cc1cccc(-c2c(Cl)nc3ncnn3c2N2CCC(C)CC2)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 0.44
ALDH1A1 P00352 4/20 0.44
TSHR P16473 4/20 0.41
MAPT P10636 4/20 0.41
NPSR1 Q6W5P4 3/20 0.38
GLA P06280 1/20 0.38
PDE2A O00408 9/20 0.38
EGLN2 Q96KS0 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
TP53 P04637 2/20 0.36
MAPK1 P28482 2/20 0.36
HSD17B10 Q99714 2/20 0.36
USP2 O75604 1/20 0.36
ALOX15 P16050 1/20 0.36
HTT P42858 1/20 0.36
HPGD P15428 2/20 0.35
KDM4E B2RXH2 1/20 0.35
NPC1 O15118 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5228613 0.84 LMNA (0.48) LMNAALDH1A1TSHRMAPTNPSR1
SCHEMBL15341363 0.84 LMNA (0.43) LMNAALDH1A1TSHRMAPTNPSR1
SCHEMBL4820371 0.82 TSHR (0.48) LMNAALDH1A1TSHRMAPTNPSR1
SCHEMBL8917364 0.80 LMNA (0.44) LMNAALDH1A1TSHRMAPTNPSR1
SCHEMBL4928661 0.80 ALDH1A1 (0.41) LMNAALDH1A1TSHRMAPTNPSR1
SCHEMBL344327 0.80 TSHR (0.46) LMNAALDH1A1TSHRMAPTNPSR1
SCHEMBL4925803 0.79 LMNA (0.39) LMNAALDH1A1TSHRMAPTNPSR1
SCHEMBL8390256 0.79 LMNA (0.47) LMNAALDH1A1TSHRMAPTNPSR1
SCHEMBL4935032 0.79 KDM4E (0.41) LMNAALDH1A1TSHRMAPTMAPK1
SCHEMBL7491155 0.78 TSHR (0.41) LMNAALDH1A1TSHRMAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080227796-A1 7-Amino-6-Hetaryl-1,2,4-Triazolo[1,5-A]Pyrimidine Compounds and the Use Thereof for Controlling Pathogenic Fungi BASF AKTIENGESELLSCHAFT (DE) 2008-09-18 US disclosed
EP-1828191-A2 7-AMINO-6-HETARYL-1,2,4-TRIAZOLO[1,5-A]PYRIMIDINE COMPOUNDS AND THE USE THEREOF FOR CONTROLLING PATHOGENIC FUNGI BASF AKTIENGESELLSCHAFT (DE) 2007-09-05 EP disclosed
WO-2006066818-A2 7-AMINO-6-HETARYL-1,2,4-TRIAZOLO[1,5-A]PYRIMIDINE COMPOUNDS AND THE USE THEREOF FOR CONTROLLING PATHOGENIC FUNGI BASF AKTIENGESELLSCHAFT (DE) 2006-06-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080227796-A1 7-Amino-6-Hetaryl-1,2,4-Triazolo[1,5-A]Pyrimidine Compounds and the Use Thereof for Controlling Pathogenic Fungi CYP8B1, CBR3, HDHD5 LMNA 961/4885ALDH1A1 2419/4885TSHR 3105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.